We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Mutant Spike Proteins and Antigens for SARS-CoV-2 Variant Research

Product News   Feb 17, 2021

 
Mutant Spike Proteins and Antigens for SARS-CoV-2 Variant Research

Credit: amsbio

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

BellBrook Labs Awarded Phase II Grant to Develop Drugs for Lupus and Related Autoimmune Diseases

Product News

BellBrook Labs has been awarded a $1.8 million Phase II SBIR grant for the treatment of lupus and other autoimmune diseases.

READ MORE

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Product News

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.

READ MORE

Adaptate Biotherapeutics Raises $18 million in Series A2 Funding

Product News

Adaptate Biotherapeutics has announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE